Wikipedia -WSS

Wikipedia

author：leisure time 2025-09-27 12:54:26 - browse：8

Monica Bertagnolli -- Health Policy coverage from STAT — Dr. Monica Bertagnolli speaks during a visit from first lady Jill Biden to the University of California San Francisco Helen Diller Family Comprehensive Cancer Center in San Francisco, Friday, Oct. 7, 2022. (AP Photo/Jeff Chiu, Pool) Jeff Chiu/AP

WASHINGTON — Sen. Bernie Sanders (I-Vt.) will hold a confirmation hearing next month for Monica Bertagnolli, President Biden’s nominee to run the National Institutes of Health, he said Friday.

Sanders, whose health committee oversees the confirmation of the NIH nominee, had refused to hold a hearing on Bertagnolli until the Biden administration promised more drug pricing reform.

Newsletters

Sign up for D.C. Diagnosis

An insider's guide to the politics and policies of health care.

Please enter a valid email address. Privacy Policy

HHS announced Friday a deal with Regeneron on the development of the Covid-19 monoclonal antibody. That deal seems to have satisfied Sanders’ demands, though Sanders said the administration must add reasonable pricing provisions to all drugs developed with the help of government funding.

“I welcome the Biden Administration’s announcement today that if Regeneron, through a $326 million contract recently signed with HHS, successfully develops a next generation monoclonal antibody for Covid-19 prevention, the list price of this drug must be equal to or lower than the price in other major countries,” Sanders said in a release.

Sen. Elizabeth Warren (D-Mass.) also had withheld support for Bertagnolli’s nomination until Bertagnolli agreed to Warren’s ethics demands. Bertagnolli agreed to not join the pharmaceutical industry or accept payment from the drug industry, until at least four years after leaving her government position.

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Woman returns to dialysis after doctors remove transplanted pig kidney

WSS

Supreme Court strikes down use of affirmative action

Kaiser's Risant Health gobbled up Geisinger. Who is next?

Heart attack and stroke risk calculators need revising

At ASCO, AstraZeneca reports strong data for breast cancer drug

See how much Covid

Ultragenyx gene therapy for rare liver ailment succeeds in late

Wikipedia

Wikipedia

Sign up for D.C. Diagnosis

entertainment

Guidelines to prevent youth baseball injuries need more muscle

Anesthesiologist group: stop taking Ozempic before surgery

Medical records are filled with copy

Medicare proposal to cover medical devices draws a mixed reaction

George Santos makes 1st court appearance after pleading not guilty to 13 counts

ASCO Daily Recap: Safety data from Novartis, survival from Pfizer

Apple is now the first public company to be valued at $3 trillion

New air purifier tech could be key to improving indoor air quality

Continuity nursing helped my family in our darkest PICU moments

State Dept. review finds Biden bears some blame for Afghanistan failures

knowledge

HIV drugs protect against transmission, even in unprotected sex

Duchenne breakthrough therapy leaves behind pioneering families

Drug repurposing or repositioning? The language matters

ASCO 2024: 'Reassuring' Corbus data on ADC bladder cancer drug

State Dept. review finds Biden bears some blame for Afghanistan failures

The Pandemic Treaty must support building strong health systems

hotspot

focus

leisure time

hotspot